175 related articles for article (PubMed ID: 35943620)
1. T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study.
Wei M; Zhang Y; Bai G; Ding C; Xu H; Dai Y; Chen S; Wang H
Insights Imaging; 2022 Aug; 13(1):130. PubMed ID: 35943620
[TBL] [Abstract][Full Text] [Related]
2. MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study.
Li Y; Jian J; Pickhardt PJ; Ma F; Xia W; Li H; Zhang R; Zhao S; Cai S; Zhao X; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Lu J; Deng L; Wu X; Qiang J; Gao X
J Magn Reson Imaging; 2020 Sep; 52(3):897-904. PubMed ID: 32045064
[TBL] [Abstract][Full Text] [Related]
3. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms.
Song XL; Ren JL; Zhao D; Wang L; Ren H; Niu J
Eur Radiol; 2021 Jan; 31(1):368-378. PubMed ID: 32767049
[TBL] [Abstract][Full Text] [Related]
4. MRI radiomics-based machine learning model integrated with clinic-radiological features for preoperative differentiation of sinonasal inverted papilloma and malignant sinonasal tumors.
Gu J; Yu Q; Li Q; Peng J; Lv F; Gong B; Zhang X
Front Oncol; 2022; 12():1003639. PubMed ID: 36212455
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-based deep learning radiomics model for differentiating benign, borderline, and malignant ovarian tumours: a multi-class classification exploratory study.
Du Y; Guo W; Xiao Y; Chen H; Yao J; Wu J
BMC Med Imaging; 2024 Apr; 24(1):89. PubMed ID: 38622546
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype.
Xu Y; Luo HJ; Ren J; Guo LM; Niu J; Song X
Front Oncol; 2022; 12():978123. PubMed ID: 36544703
[TBL] [Abstract][Full Text] [Related]
7. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
8. Associating Peritoneal Metastasis With T2-Weighted MRI Images in Epithelial Ovarian Cancer Using Deep Learning and Radiomics: A Multicenter Study.
Wei M; Zhang Y; Ding C; Jia J; Xu H; Dai Y; Feng G; Qin C; Bai G; Chen S; Wang H
J Magn Reson Imaging; 2024 Jan; 59(1):122-131. PubMed ID: 37134000
[TBL] [Abstract][Full Text] [Related]
9. Multiphasic CT-Based Radiomics Analysis for the Differentiation of Benign and Malignant Parotid Tumors.
Yu Q; Wang A; Gu J; Li Q; Ning Y; Peng J; Lv F; Zhang X
Front Oncol; 2022; 12():913898. PubMed ID: 35847942
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Ovarian Neoplasms Using Nomogram in Combination With Ultrasound Image-Based Radiomics Signature and Clinical Factors.
Qi L; Chen D; Li C; Li J; Wang J; Zhang C; Li X; Qiao G; Wu H; Zhang X; Ma W
Front Genet; 2021; 12():753948. PubMed ID: 34650603
[No Abstract] [Full Text] [Related]
11. MRI-based radiomics analysis for differentiating phyllodes tumors of the breast from fibroadenomas.
Tsuchiya M; Masui T; Terauchi K; Yamada T; Katyayama M; Ichikawa S; Noda Y; Goshima S
Eur Radiol; 2022 Jun; 32(6):4090-4100. PubMed ID: 35044510
[TBL] [Abstract][Full Text] [Related]
12. CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors.
Zheng Y; Zhou D; Liu H; Wen M
Eur Radiol; 2022 Oct; 32(10):6953-6964. PubMed ID: 35484339
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
14. Deep Learning Radiomics Nomogram Based on Magnetic Resonance Imaging for Differentiating Type I/II Epithelial Ovarian Cancer.
Wei M; Feng G; Wang X; Jia J; Zhang Y; Dai Y; Qin C; Bai G; Chen S
Acad Radiol; 2023 Aug; ():. PubMed ID: 37643927
[TBL] [Abstract][Full Text] [Related]
15. A combined radiomics and clinical variables model for prediction of malignancy in T2 hyperintense uterine mesenchymal tumors on MRI.
Wang T; Gong J; Li Q; Chu C; Shen W; Peng W; Gu Y; Li W
Eur Radiol; 2021 Aug; 31(8):6125-6135. PubMed ID: 33486606
[TBL] [Abstract][Full Text] [Related]
16. Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
Wang H; Hu D; Yao H; Chen M; Li S; Chen H; Luo J; Feng Y; Guo Y
Eur Radiol; 2019 Nov; 29(11):6182-6190. PubMed ID: 31016445
[TBL] [Abstract][Full Text] [Related]
17. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract][Full Text] [Related]
18. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
19. CT-Based Radiomics and Machine Learning for Differentiating Benign, Borderline, and Early-Stage Malignant Ovarian Tumors.
Chen J; Liu L; He Z; Su D; Liu C
J Imaging Inform Med; 2024 Feb; 37(1):180-195. PubMed ID: 38343232
[TBL] [Abstract][Full Text] [Related]
20. Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics.
Starmans MPA; Miclea RL; Vilgrain V; Ronot M; Purcell Y; Verbeek J; Niessen WJ; Ijzermans JNM; de Man RA; Doukas M; Klein S; Thomeer MG
Acad Radiol; 2024 Mar; 31(3):870-879. PubMed ID: 37648580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
